| A Dose Response Study of Dabigatran Etexilate(BIBR 1048) in Pharmacodynamics and Safety in Patients With Non-valvular Atrial Fibrillation in Comparison to Warfarin (NCT01136408) | Boehringer Ingelheim | 2005-11-01 |
| Electrophysiologically Guided PAcing Site Selection Study (NCT00239226) | Medtronic BRC | 2005-11-01 |
| Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke (NCT00240643) | GlaxoSmithKline | 2005-11-01 |
| After Discharge Management of Low Income Frail Elderly (NCT00328848) | Summa Health System | 2005-10-01 |
| Double Blind Placebo COntrolled Dose Ranging studY of the eFficacy and safEty of SSR149744c 300 or 600 mg for the Conversion of Atrial Fibrillation / fluttEr (NCT00232310) | Sanofi | 2005-10-01 |
| First Arrhythmia Collection of Transvenous and Simultaneous Subcutaneous Implantable Defibrillator Data (NCT01161589) | Boston Scientific Corporation | 2005-10-01 |
| Atorvastatin Therapy for the Prevention of Atrial Fibrillation (SToP-AF) (NCT00252967) | Emory University | 2005-10-01 |
| Study of RSD1235 to Evaluate Safety in Patients With Atrial Fibrillation (NCT00281554) | Astellas Pharma Inc | 2005-10-01 |
| FLAT Study: First Line Ablation Therapy for Treatment of Paroxysmal Atrial Fibrillation (RAAFT) (NCT00137540) | Biosense Webster EMEA | 2005-09-01 |
| Prevention of Atrial Fibrillation Following Esophagectomy (NCT00420017) | Indiana University | 2005-09-01 |
| BAY59-7939 Japanese in Atrial Fibrillation (2nd) (NCT00973323) | Bayer | 2005-09-01 |
| Radiofrequency Ablation (RFA) Versus Antiarrhythmic Drug Treatment in Paroxysmal Atrial Fibrillation (NCT00133211) | Danish Heart Foundation | 2005-09-01 |
| Clinical and Economic Consequences of Left Atrial Bipolar Radiofrequency Ablation of Persistent and Permanent Atrial Fibrillation During Cardiac Surgery (NCT00157807) | Medtronic Cardiac Surgery | 2005-09-01 |
| Transesophageal Echocardiography to Identify pAtients With Low Risk of Stroke in Atrial Fibrillation - TIARA Pilot Study (NCT00224757) | The Interuniversity Cardiology Institute of the Netherlands | 2005-09-01 |
| Efficacy and Safety of AZD7009 in the Treatment of Atrial Fibrillation (NCT00255281) | AstraZeneca | 2005-09-01 |
| Identification of Genetic, Biochemical and Hormonal Factors Contributing to Atrial Fibrillation (NCT00599118) | The Cleveland Clinic | 2005-08-01 |
| Treatment of Subclinical Hyperthyroidism (NCT00213720) | University Hospital, Strasbourg, France | 2005-08-01 |
| Effects of Left Atrial Appendage Occlusion (NCT00510900) | University of Pittsburgh | 2005-08-01 |
| Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation (NCT00111488) | Boston Scientific Corporation | 2005-06-01 |
| Markers of Oxidative Stress Present in Blood in Patients With Atrial Fibrillation (NCT00142194) | Emory University | 2005-06-01 |
| A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation (NCT00174785) | Sanofi | 2005-06-01 |
| A Prospective Multi Centre Trial on Bipolar Radiofrequency Ablation of Atrial Fibrillation (NCT00184249) | Norwegian University of Science and Technology | 2005-06-01 |
| Silent Cerebrovascular Lesion and Cognitive Decline Prevention by Cholesterol Lowering in Elderly AF Patients (NCT00449410) | Radboud University Medical Center | 2005-05-01 |
| SAFE Study - Septal Pacing for Atrial Fibrillation Suppression Evaluation (NCT00419640) | Abbott Medical Devices | 2005-05-01 |
| APAF: Assessment of Cardiac Resynchronization Therapy in Patients With Permanent Atrial Fibrillation (NCT00111527) | Azienda USL Reggio Emilia - IRCCS | 2005-05-01 |
| Markers of Oxidative Stress Present in Left Atrial Appendage Tissue in Patients With Atrial Fibrillation (NCT00243802) | Emory University | 2005-05-01 |
| Medical Economical Evaluation of the Ablation by Catheter of the Atrial Tissue in the Treatment of AF (NCT01183091) | Assistance Publique - Hôpitaux de Paris | 2005-04-01 |
| Atrial Fibrillation Rate Control Therapy Guided By Continuous Ambulatory Monitoring (NCT00115843) | Beth Israel Deaconess Medical Center | 2005-04-01 |
| Renin-angiotensin-aldosterone System (RAAS), Inflammation, and Post-Operative Atrial Fibrillation (AF) (NCT00141778) | Vanderbilt University | 2005-04-01 |
| Catheter Ablation Versus Medical Treatment of AF in Heart Failure (NCT01411371) | Barts & The London NHS Trust | 2005-03-01 |
| Intra-Cardiac Echocardiography Guided Cardioversion(ICE-CHIP) Study (NCT00281073) | EP MedSystems | 2005-03-01 |
| Flecainide-Short Long Study (Flec-SL) (NCT00215774) | Atrial Fibrillation Network | 2005-03-01 |
| WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients With Atrial Fibrillation (NCT00129545) | Boston Scientific Corporation | 2005-02-01 |
| Biochemical Marker to Predict the Recurrence of Atrial Fibrillation After Surgical Maze Procedure (NCT00542659) | Samsung Medical Center | 2005-02-01 |
| Biatrial Contractility Recovery After Maze (NCT02303652) | Centro Cardiologico Monzino | 2005-01-01 |
| Omega 3 Fatty Acids and Atrial Fibrillation (NCT00508248) | University of Dundee | 2005-01-01 |
| Trial to Investigate the Efficacy of Olmesartan in Paroxysmal Atrial Fibrillation (NCT00098137) | Atrial Fibrillation Network | 2005-01-01 |
| The Genetic Basis of Atrial Fibrillation (AF) (NCT00248326) | University of Pittsburgh | 2005-01-01 |
| Atrial Tissue Banking: Atrial Tissue Obtained From Patients Undergoing Heart Surgery (NCT00248274) | University of Pittsburgh | 2005-01-01 |
| A Trial of Circumferential Pulmonary Vein Ablation (CPVA) Versus Antiarrhythmic Drug Therapy in for Paroxysmal Atrial Fibrillation (AF) (NCT00340314) | IRCCS San Raffaele | 2005-01-01 |
| Concomitant Treatment of Permanent Atrial Fibrillation (NCT00566787) | AtriCure, Inc. | 2005-01-01 |
| A Case Control Study to Investigate the Possible Association Between Atrial Fibrillation and Endothelium Dysfunction by Using Flow-Mediated Vasodilation Method (NCT00173966) | National Taiwan University Hospital | 2005-01-01 |
| Recurrence of Atrial Fibrillation in Patients With Dual-chamber Pacemakers and Drug Therapy (NCT00215761) | Atrial Fibrillation Network | 2005-01-01 |
| Carvedilol Versus Metoprolol for the Prevention of Atrial Fibrillation After Off-Pump Coronary Bypass Surgery (NCT00198614) | Ministry of Health, Labour and Welfare, Japan | 2005-01-01 |
| CACAF2 Study: Catheter Ablation for Cure of Atrial Fibrillation (NCT00227344) | Biosense Webster EMEA | 2004-12-01 |
| Investigational Device Exemption (IDE) Study for the Approval of Closed Loop Stimulation (CLS) and Cardiac Resyncronization Pacing Therapies (CRT) for the Treatment of Atrial Fibrillation (AF) With Ablate and Pace (NCT00356057) | Biotronik, Inc. | 2004-12-01 |
| Placebo Controlled Double-blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/Flutter (NCT00233441) | Sanofi | 2004-12-01 |
| Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects (NCT00126022) | Solvay Pharmaceuticals | 2004-12-01 |
| GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence (NCT00376272) | Gruppo di Ricerca GISSI | 2004-11-01 |
| Cavotricuspid Isthmusblock and Circumferential Pulmonary Vein Isolation in Patients With Atrial Fibrillation (NCT00247780) | University of Aarhus | 2004-11-01 |
| The Use of DIOVAN to Reduce Post-Cardioversion Recurrence of Atrial Fibrillation Trial (the DRAFT Trial) (NCT00343499) | Intermountain Health Care, Inc. | 2004-11-01 |
| NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation (NCT00116428) | Biosense Webster, Inc. | 2004-10-01 |
| Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Male Subjects (NCT00126061) | Solvay Pharmaceuticals | 2004-10-01 |
| Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects (NCT00126074) | Solvay Pharmaceuticals | 2004-10-01 |
| Inflammation as a Predictor in Cardioversion of Atrial Fibrillation (NCT00590525) | Creighton University | 2004-10-01 |
| Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial (NCT00256152) | Abbott Medical Devices | 2004-09-01 |
| Prevention of Atrial Fibrillation Following Noncardiac Thoracic Surgery (NCT00127712) | Indiana University | 2004-09-01 |
| MODULA Modul 7 VRR (NCT00180414) | Boston Scientific Corporation | 2004-08-28 |
| Trigger- vs. Substrate-Ablation for Paroxysmal Atrial Fibrillation (NCT00196183) | Deutsches Herzzentrum Muenchen | 2004-08-01 |
| Line Versus Spot Ablation in Persistent Atrial Fibrillation (NCT00196157) | Deutsches Herzzentrum Muenchen | 2004-08-01 |
| Safety and Efficacy Study of RENEWAL 4 AVT (NCT00180336) | Boston Scientific Corporation | 2004-07-01 |
| BAY59-7939, Japanese Phase II in Atrial FibrillationTrial Status (NCT00779064) | Bayer | 2004-07-01 |
| Study to Determine the Response and Effectiveness of RSD1235 in Subjects With Atrial Fibrillation or Atrial Flutter (NCT00115791) | Astellas Pharma Inc | 2004-06-01 |
| Response to RSD1235 Compared to Placebo in Subjects With Atrial Arrhythmia After Heart Surgery (NCT00125320) | Astellas Pharma Inc | 2004-06-01 |
| Safety Monitoring of Patients Having Pulmonary Vein Ablation (NCT00590668) | The Cleveland Clinic | 2004-05-01 |
| Usefulness of Markers to Predict Recurrence of Atrial Fibrillation After Radiofrequency Catheter Ablation (NCT00315068) | University Hospital, Geneva | 2004-04-01 |
| Prospective Registration and Assessment of Serious Adverse Events Within the AFNET (NCT01678456) | Atrial Fibrillation Network | 2004-02-01 |
| Reducing Episodes by Septal Pacing Efficacy Confirmation Trial (RESPECT) (NCT00289289) | Medtronic Cardiac Rhythm and Heart Failure | 2004-02-01 |
| Reduction of Atrial Fibrillation Study in Patients Undergoing Coronary Artery Bypass Grafting. (RASCABG 1 Study) (NCT00287209) | University of Aarhus | 2004-01-01 |
| Atrial Fibrillation and the Risk for Neurological Complications (NCT00357227) | University Hospital Muenster | 2004-01-01 |
| Use of Fish Oils to Reduce the Frequency and Duration of Episodes of Atrial Fibrillation in Patients With Paroxysmal Atrial Fibrillation. (NCT00232245) | Melbourne Health | 2003-12-01 |
| Long-term, Open-label Follow-up Treatment of Patients With A-fib Who Have Been Previously Treated With BIBR 1048 (NCT00157248) | Boehringer Ingelheim | 2003-12-01 |
| CORE: Study to Evaluate the Conducted AF-Response-Algorithm in Patients Suffering From Heart Failure and Atrial Fibrillation (NCT00170313) | Medtronic Cardiac Rhythm and Heart Failure | 2003-12-01 |
| TRENDS: A Prospective Study of the Clinical Significance of Atrial Arrhythmias Detected by Implanted Device Diagnostics (NCT00279981) | Medtronic Cardiac Rhythm and Heart Failure | 2003-11-01 |
| CONTAK RENEWAL 3 AVT (NCT00158977) | Boston Scientific Corporation | 2003-11-01 |
| Pharmacogenetics and Cardiovascular Events (NCT00094198) | National Heart, Lung, and Blood Institute (NHLBI) | 2003-09-01 |
| Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS) (NCT00070655) | Sanofi | 2003-09-01 |
| PETRO Stroke Prevention in Patients With AF by Treatment With Dabigatran, With and Without Aspirin, Compared to Warfarin (NCT01227629) | Boehringer Ingelheim | 2003-09-01 |
| Use of Fish Oils to Prevent Atrial Mechanical Stunning and Atrial Remodeling Due to Atrial Arrhythmia (NCT00232232) | Melbourne Health | 2003-09-01 |
| To Evaluate the Impact of Oral Flecainide on Quality of Life in Patients With Paroxysmal Atrial Fibrillation (NCT00189319) | MEDA Pharma GmbH & Co. KG | 2003-09-01 |
| Mascot Study: Management of Atrial Fibrillation (AF) Suppression in AF-Heart Failure (HF) COmorbidity Therapy (NCT00187252) | Abbott Medical Devices | 2003-09-01 |
| The Home INR Study (NCT00032591) | US Department of Veterans Affairs | 2003-08-01 |
| Phase III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Fibrillation (NCT00468767) | Advanz Pharma | 2003-08-01 |
| Dual Chamber Versus Single Chamber Cardiac Pacing in People 80 Years of Age and Older (NCT00116987) | University of Calgary | 2003-08-01 |
| Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W) (NCT00243178) | Sanofi | 2003-07-01 |
| A Study of Strategies for Electrical Isolation of Pulmonic Veins for Curative Treatment of Atrial Fibrillation (NCT00434694) | University of Pennsylvania | 2003-07-01 |
| Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I) (NCT00249795) | Sanofi | 2003-06-01 |
| Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A) (NCT00249873) | Sanofi | 2003-06-01 |
| Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC Cardioversion (NCT00232219) | Melbourne Health | 2003-01-01 |
| SAVEPACe - Search AV Extension and Managed Ventricular Pacing for Promoting Atrio-Ventricular Conduction (NCT00284830) | Medtronic Cardiac Rhythm and Heart Failure | 2003-01-01 |
| Ten-year Outcomes After AF Ablation (NCT01867099) | Valley Health System | 2002-12-01 |
| Comparison of Pulmonary Vein Isolation Versus AV Nodal Ablation With Biventricular Pacing for Patients With Atrial Fibrillation With Congestive Heart Failure (PABA CHF) (NCT00599976) | Azienda Policlinico Umberto I | 2002-11-01 |
| Radiofrequency Catheter Ablation for Chronic Atrial Fibrillation (NCT00272636) | University of Michigan | 2002-11-01 |
| A Randomized Trial of the Ostial Versus the Extra-Ostial Ablation Strategy for Atrial Fibrillation (NCT00192972) | Rigshospitalet, Denmark | 2002-11-01 |
| Atrial Fibrillation: Canadian Atrial Fibrillation Evaluation (CAFE) Study - (NCT00848445) | Boston Scientific Corporation | 2002-10-01 |
| The Effect of Arrhythmia Surgery on Quality of Life in Patients With Atrial Fibrillation Undergoing Cardiac Surgery (NCT00886080) | Maastricht University Medical Center | 2002-10-01 |
| The Value of add-on Arrhythmia Surgery in Patients With Atrial Fibrillation Undergoing Cardiac Surgery (NCT01019759) | Maastricht University Medical Center | 2002-09-01 |
| European Study of Dronedarone in Atrial Fibrillation (NCT00697086) | Sanofi | 2002-08-01 |
| Genetic Determinants of Warfarin Anticoagulation Effect (NCT00162435) | Hadassah Medical Organization | 2002-08-01 |
| Prevention of Atrial Fibrillation by Optimized Overdrive Stimulation (NCT01912326) | Abbott Medical Devices | 2002-07-01 |